NO20013301L - Ny dialysemetode - Google Patents

Ny dialysemetode

Info

Publication number
NO20013301L
NO20013301L NO20013301A NO20013301A NO20013301L NO 20013301 L NO20013301 L NO 20013301L NO 20013301 A NO20013301 A NO 20013301A NO 20013301 A NO20013301 A NO 20013301A NO 20013301 L NO20013301 L NO 20013301L
Authority
NO
Norway
Prior art keywords
dialysis method
dialysis
new dialysis
molecular weight
low molecular
Prior art date
Application number
NO20013301A
Other languages
English (en)
Other versions
NO326996B1 (no
NO20013301D0 (no
Inventor
Gunnar Fager
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20013301L publication Critical patent/NO20013301L/no
Publication of NO20013301D0 publication Critical patent/NO20013301D0/no
Publication of NO326996B1 publication Critical patent/NO326996B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3427—Substitution fluid path back through the membrane, e.g. by inverted trans-membrane pressure [TMP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anvendelse av en trombininhibitor av lav molekylvekt for fremstilling av et legemiddel for behandling ved dialyse, spesielt hemodialyse, av en pasient som har behov for slik behandling, hvor trombininhibitoren tilveiebringes i dialyseoppløsningen, samt dialyse-oppløsninger og konsentrater innbefattende trombininhibitorer av lav molekylvekt, slik som melagatran.
NO20013301A 1999-01-11 2001-07-03 Anvendelse av trombininhibitor for fremstilling av et medikament for dialysebehandling. NO326996B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900043A SE9900043D0 (sv) 1999-01-11 1999-01-11 New use
PCT/SE2000/000030 WO2000041715A1 (en) 1999-01-11 2000-01-11 New dialysis method

Publications (3)

Publication Number Publication Date
NO20013301L true NO20013301L (no) 2001-07-03
NO20013301D0 NO20013301D0 (no) 2001-07-03
NO326996B1 NO326996B1 (no) 2009-03-30

Family

ID=20414050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013301A NO326996B1 (no) 1999-01-11 2001-07-03 Anvendelse av trombininhibitor for fremstilling av et medikament for dialysebehandling.

Country Status (19)

Country Link
US (4) US20030042202A1 (no)
EP (1) EP1144000B1 (no)
JP (1) JP4054533B2 (no)
KR (1) KR100840452B1 (no)
CN (1) CN100387296C (no)
AT (1) ATE316384T1 (no)
AU (1) AU763185B2 (no)
BR (1) BR0007448A (no)
CA (1) CA2356440A1 (no)
CY (1) CY1107461T1 (no)
DE (1) DE60025698T2 (no)
DK (1) DK1144000T3 (no)
ES (1) ES2255968T3 (no)
IL (1) IL143824A0 (no)
NO (1) NO326996B1 (no)
NZ (1) NZ512712A (no)
SE (1) SE9900043D0 (no)
WO (1) WO2000041715A1 (no)
ZA (1) ZA200105274B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371729B2 (en) 2002-09-09 2008-05-13 Trigen Limited Boronic acid salts useful in parenteral formulations
JP2006511593A (ja) 2002-09-09 2006-04-06 トライジェン・リミテッド ボロン酸塩および血栓症の治療におけるその使用
US7235589B2 (en) * 2004-09-21 2007-06-26 Bio Numerik Pharmaceuticals, Inc. Method of treating patients undergoing kidney dialysis
KR101423938B1 (ko) 2005-12-21 2014-08-06 메소 스케일 테크놀러지즈, 엘엘시 분석 장치, 방법 및 시약
CN105115949B (zh) * 2005-12-21 2018-06-22 梅索斯卡莱科技公司 分析装置、方法和试剂
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
CN103889481B (zh) * 2011-08-02 2016-03-09 美敦力公司 带有具有可控的顺应性容积的流动路径的血液透析系统
US9623164B2 (en) 2013-02-01 2017-04-18 Medtronic, Inc. Systems and methods for multifunctional volumetric fluid control
US10010663B2 (en) 2013-02-01 2018-07-03 Medtronic, Inc. Fluid circuit for delivery of renal replacement therapies
US10850016B2 (en) 2013-02-01 2020-12-01 Medtronic, Inc. Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection
US9713665B2 (en) 2014-12-10 2017-07-25 Medtronic, Inc. Degassing system for dialysis
US10098993B2 (en) 2014-12-10 2018-10-16 Medtronic, Inc. Sensing and storage system for fluid balance
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
US11278654B2 (en) 2017-12-07 2022-03-22 Medtronic, Inc. Pneumatic manifold for a dialysis system
US11033667B2 (en) 2018-02-02 2021-06-15 Medtronic, Inc. Sorbent manifold for a dialysis system
US11110215B2 (en) 2018-02-23 2021-09-07 Medtronic, Inc. Degasser and vent manifolds for dialysis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
JPH10513462A (ja) * 1995-02-10 1998-12-22 ビーエーエスエフ アクチェンゲゼルシャフト トロンビンインヒビター
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US6034067A (en) * 1996-02-13 2000-03-07 Akzo Nobel, N.V. Serine protease inhibitors
EP0884325A1 (en) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
ES2232946T3 (es) * 1997-04-30 2005-06-01 Eli Lilly And Company Agentes antitromboticos.
WO1998048800A1 (en) * 1997-05-01 1998-11-05 Eli Lilly And Company Antithrombotic agents
RU2183642C2 (ru) * 1997-05-02 2002-06-20 Акцо Нобель Н.В. Ингибиторы сериновых протеаз

Also Published As

Publication number Publication date
KR20010093250A (ko) 2001-10-27
US20030042202A1 (en) 2003-03-06
EP1144000A1 (en) 2001-10-17
US20050153904A1 (en) 2005-07-14
NO326996B1 (no) 2009-03-30
CY1107461T1 (el) 2012-12-19
AU763185B2 (en) 2003-07-17
CN100387296C (zh) 2008-05-14
US20080004225A1 (en) 2008-01-03
DK1144000T3 (da) 2006-05-08
JP2002534217A (ja) 2002-10-15
CN1354673A (zh) 2002-06-19
ATE316384T1 (de) 2006-02-15
WO2000041715A1 (en) 2000-07-20
CA2356440A1 (en) 2000-07-20
SE9900043D0 (sv) 1999-01-11
DE60025698T2 (de) 2006-10-19
IL143824A0 (en) 2002-04-21
KR100840452B1 (ko) 2008-06-20
ZA200105274B (en) 2002-09-26
JP4054533B2 (ja) 2008-02-27
AU2140900A (en) 2000-08-01
US20090192137A1 (en) 2009-07-30
BR0007448A (pt) 2001-10-16
ES2255968T3 (es) 2006-07-16
NZ512712A (en) 2004-09-24
DE60025698D1 (de) 2006-04-13
EP1144000B1 (en) 2006-01-25
NO20013301D0 (no) 2001-07-03

Similar Documents

Publication Publication Date Title
NO20013301L (no) Ny dialysemetode
DE60039301D1 (de) Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus
NO20060416L (no) Ny anvendelse I
EP1271386A3 (en) Apparatus and process for assessing medical facilities
AR042795A1 (es) Fluidos de dialisis biocompatibles que contienen icodextrinas
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
HUP9900926A2 (hu) Új (4-oxialkoxi-fenil)-3-oxi-piperidinek, szív- és veseelégtelenség kezelésére
WO2004010937A3 (en) Method of treating cancer
ATE337786T1 (de) Verwendung von taurolidine oder taurultam zur behandlung und prävention von infektionen in medizinischen freisetzungssystemen
CY1105068T1 (el) ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa
ATE405277T1 (de) Substitutions-infusionflüssigkeit und zitratanticoagulation
NO20054459L (no) Liposompreparat for reduksjon av liposomindusert komplementaktivering
NO20020056D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons
ATE373725T1 (de) Methoden zur feststellung von akute myeloischen leukämie
PT1196185E (pt) Nova utilizacao de solucoes salinas hipo-osmoticas e medicamento a base de tais solucoes
NO20051390L (no) Fremgangsmate for behandling av pasienter med massivt blodtap
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DE60117762D1 (de) Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten
GB0007239D0 (en) Use
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
NO985558L (no) Ny forbedret formulering for behandling av tromboembolisme

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees